GLOBUS MEDICAL, INC. Cash and Restricted Cash
GLOBUS MEDICAL, INC. (GMED) had Cash and Restricted Cash of $507.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $507.75M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $560.95M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $526.16M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $371.77M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $507.75M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $560.95M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $526.16M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $371.77M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $229.45M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $461.27M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $784.44M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $622.77M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $410.42M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $354.06M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $467.29M 10-K · filed 2026-02-24 |
| 2023-09-30 | $279.62M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $306.45M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $217.69M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $150.47M 10-K · filed 2026-02-24 |
| 2022-09-30 | $134.22M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $150.77M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $229.79M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $193.07M 10-K · filed 2025-02-20 |
| 2021-09-30 | $361.88M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $268.78M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $184.85M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $239.40M 10-K · filed 2024-02-21 |
| 2020-09-30 | $250.61M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $165.55M 10-Q · filed 2021-08-04 |
| 2020-03-31 | $166.74M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $195.72M 10-K · filed 2023-02-21 |
| 2019-09-30 | $166.19M 10-Q · filed 2020-10-28 |
| 2019-06-30 | $117.79M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $129.98M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $139.75M 10-K · filed 2022-02-17 |
| 2018-09-30 | $145.29M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $119.94M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $119.84M 10-Q · filed 2019-05-02 |
| 2017-12-31 | $118.82M 10-K · filed 2021-02-17 |
| 2017-09-30 | $90.23M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $89.22M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $107.26M 10-Q · filed 2018-05-03 |
| 2016-12-31 | $67.43M 10-K/A · filed 2020-03-02 |
| 2015-12-31 | $83.77M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |